Jieyi Biotechnology

Hangzhou, China Founded: 2019 • Age: 7 yrs
Sequencing-based platform for microorganism detection in patients is developed.
Request Access

About Jieyi Biotechnology

Jieyi Biotechnology is a company based in Hangzhou (China) founded in 2019 by Wang Jun.. Jieyi Biotechnology operates in a competitive market with competitors including Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others.

  • Headquarter Hangzhou, China
  • Founders Wang Jun
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Jieyi Biotechnology

  • Total Funding
  • Total Rounds 5
  • Last Round
  • First Round
  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
Feb, 2024 Amount Series C - Jieyi Biotechnology Valuation

investors

Sep, 2021 Amount Series B - Jieyi Biotechnology Valuation Alibaba Group , Huatai Zijin Investment
Jan, 2021 Amount Series B - Jieyi Biotechnology Valuation CD Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Jieyi Biotechnology

Jieyi Biotechnology has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Alibaba Group, Huatai Zijin Investment and Qianhai Ark Asset Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Jieyi Biotechnology

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Jieyi Biotechnology

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jieyi Biotechnology Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Jieyi Biotechnology

Jieyi Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, OpGen, Day Zero Diagnostics, Clear Labs and Karius, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Health risks are identified through online genetic and diagnostic testing.
domain founded_year HQ Location
Developer of diagnostics and bioinformatics platforms for providers
domain founded_year HQ Location
Genome sequencing diagnostics for infectious diseases are developed.
domain founded_year HQ Location
Food safety technologies are provided for pathogen identification.
domain founded_year HQ Location
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
domain founded_year HQ Location
Nucleic acid drugs are developed via RNA interference technology.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Jieyi Biotechnology

When was Jieyi Biotechnology founded?

Jieyi Biotechnology was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Jieyi Biotechnology located?

Jieyi Biotechnology is headquartered in Hangzhou, China. It is registered at Hangzhou, Zhejiang, China.

Who is the current CEO of Jieyi Biotechnology?

Wang Jun is the current CEO of Jieyi Biotechnology. They have also founded this company.

What does Jieyi Biotechnology do?

Jieyi Biotechnology was founded in 2019 in Hangzhou, China, within the biotechnology sector. Sequencing-based diagnostic technology and platforms are developed by the company, including PDC-Seq for high-throughput nucleic acid sequencing of patient samples. Data analysis is conducted using a microbial genome database, clinical information, and software tools to identify pathogenic microorganisms and resistance genes. Operations focus on diagnostic applications for infectious diseases.

Who are the top competitors of Jieyi Biotechnology?

Jieyi Biotechnology's top competitors include Prenetics, Clear Labs and Day Zero Diagnostics.

Who are Jieyi Biotechnology's investors?

Jieyi Biotechnology has 6 investors. Key investors include Alibaba Group, Huatai Zijin Investment, Qianhai Ark Asset Management, Proxima Ventures, and CD Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available